NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States. Food and Drug Administration. Remove constraint Subjects: United States. Food and Drug Administration. Publication Year 2017 Remove constraint Publication Year: 2017

Search Results

51. Recurrent herpes labialis: developing drugs for treatment and prevention

52. Evaluating drug effects on the ability to operate a motor vehicle

53. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

54. Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception

55. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

56. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

57. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

58. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

59. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

60. Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff